Oryzon Genomics SA (ORYZF)
3.65
+0.31
(+9.28%)
USD |
OTCM |
May 19, 16:00
Oryzon Genomics EPS Diluted (Quarterly) : -0.0182 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Grifols SA | 0.1255 |
| Pharma Mar SA | 0.1033 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alkermes Plc | -0.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.408M |
| Total Expenses (Quarterly) | 1.408M |
| Enterprise Value | 257.50M |
| Earnings Yield | -0.87% |
| Normalized Earnings Yield | -0.8712 |